Coramitug is currently being investigated in the phase 3 CLEOPATTRA trial in approximately 1280 patients with ATTR-CM.

Machine learning models can predict the risk for developing moderate-to-severe persistent asthma and allergic rhinitis in children with early-life AD.

Survodutide, a dual GLP-1 and glucagon receptor agonist, significantly reduced body weight in adults with obesity in the SYNCHRONIZE-1 trial.

A new proposal could make it easier for many patients to access breakthrough medical devices through Medicare.

Individuals with screening-detected AF have a comparable risk for developing heart failure to those with clinically known AF.

Olezarsen significantly lowers triglycerides and pancreatitis risk in severe hypertriglyceridemia, with a favorable short-term safety profile.

For patients with early infection with Lyme disease, standard and modified two-tiered testing diagnostic algorithms have low sensitivity.

Topline results from the pivotal HAELO trial demonstrate that a single infusion of lonvo-z significantly reduces HAE attacks and the need for chronic prophylactic therapy.

Adult offspring exposed to HDP show significantly higher risk for hypertension, stroke, and acute coronary syndrome.

Major medical and CV journals significantly underrepresent African countries in randomized controlled trials, compared with disease burden.

Hypertension is common among post-9/11 veterans, with clinical hypertension seen in 44.9%, according to a study.

For adults with T2D, a ketogenic diet (KD) reduces the proportion of proinsulin secreted to a greater extent than a low-fat diet (LFD).